WO2002062984A1 - The yeast with immunoregulation activity to the k cell as well as the production method and the use thereof - Google Patents

The yeast with immunoregulation activity to the k cell as well as the production method and the use thereof Download PDF

Info

Publication number
WO2002062984A1
WO2002062984A1 PCT/CN2001/000117 CN0100117W WO02062984A1 WO 2002062984 A1 WO2002062984 A1 WO 2002062984A1 CN 0100117 W CN0100117 W CN 0100117W WO 02062984 A1 WO02062984 A1 WO 02062984A1
Authority
WO
WIPO (PCT)
Prior art keywords
cell
yeast
biological preparations
specific
immonological
Prior art date
Application number
PCT/CN2001/000117
Other languages
French (fr)
Chinese (zh)
Inventor
Kamfu Wong
Original Assignee
Six Forest Bio-Science Institute Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Six Forest Bio-Science Institute Limited filed Critical Six Forest Bio-Science Institute Limited
Priority to PCT/CN2001/000117 priority Critical patent/WO2002062984A1/en
Publication of WO2002062984A1 publication Critical patent/WO2002062984A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N13/00—Treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts

Abstract

The invention involves a method of simulating bioelectricity to activate the recessive gene of normal yeast to convert it a specific yeast. The specific proteins (enzymes) expressed by the specific yeast have the ability to activate, modulate and correct the immune gene in the B cell, T cell, K cell and NK cell which have deficient immonological function, respectively. Further more, the specific yeast is made into biological preparations for regulating the immune gene to rebuild immonological function of the body, such that the individuals with various diseases can recuperate their health. The biological preparations of the invention may be used in preventing and treating various diseases such as multiple type of tumors, uraemia, hepatitis, senile dementia, various gastrointestinal disease, diabetes, neural obstruction etc. The effect of the biological preparations is perfect, while no toxicity and side-effect is observed.
PCT/CN2001/000117 2001-02-08 2001-02-08 The yeast with immunoregulation activity to the k cell as well as the production method and the use thereof WO2002062984A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/CN2001/000117 WO2002062984A1 (en) 2001-02-08 2001-02-08 The yeast with immunoregulation activity to the k cell as well as the production method and the use thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2001/000117 WO2002062984A1 (en) 2001-02-08 2001-02-08 The yeast with immunoregulation activity to the k cell as well as the production method and the use thereof

Publications (1)

Publication Number Publication Date
WO2002062984A1 true WO2002062984A1 (en) 2002-08-15

Family

ID=4574771

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2001/000117 WO2002062984A1 (en) 2001-02-08 2001-02-08 The yeast with immunoregulation activity to the k cell as well as the production method and the use thereof

Country Status (1)

Country Link
WO (1) WO2002062984A1 (en)

Cited By (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1375652A3 (en) * 2002-06-28 2004-01-07 Ultra Biotech Limited Oral compositions for HIV-Infected Subjects
EP1375651A3 (en) * 2002-06-28 2004-01-07 Ultra Biotech Limited Oral compositions for white blood cell activation and proliferation
US6984507B2 (en) 2003-06-11 2006-01-10 Ultra Biotech Limited Biological compositions and methods for treatment of lung cancer
US6984508B2 (en) 2003-06-11 2006-01-10 Ultra Biotech Limited Biological compositions and methods for treatment of cervical cancer
US6987012B2 (en) 2003-06-11 2006-01-17 Ultra Biotech Limited Biological compositions and methods for treatment of colorectal cancer
US6989253B2 (en) 2003-06-11 2006-01-24 Ultra Biotech Limited Biological compositions and methods for treatment of testicular cancer
US7201906B2 (en) 2003-06-11 2007-04-10 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7204988B2 (en) 2003-06-11 2007-04-17 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7204987B2 (en) 2003-06-11 2007-04-17 Ultra Biotech Limited Biological compositions and methods for treatment of prostate cancer
US7204986B2 (en) 2003-06-11 2007-04-17 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7208158B2 (en) 2003-06-11 2007-04-24 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7214377B2 (en) 2003-06-11 2007-05-08 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7220416B2 (en) 2003-06-11 2007-05-22 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7223403B2 (en) 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7223401B2 (en) 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7223405B2 (en) 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepareompositions comprising yeast treated with electromagnetic energy
US7223400B2 (en) 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7223404B2 (en) 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7223402B2 (en) 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7226600B2 (en) 2003-06-11 2007-06-05 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
WO2011023769A1 (en) * 2009-08-26 2011-03-03 Mb Milmed Ab Composition for treatment of neurodegenerative diseases or disorders, method and use comprising electromagnetically irradiated yeast

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU902462A1 (en) * 1980-03-26 1982-08-15 Отдел Биологии Дагестанского Филиала Ан Ссср Method for cultivating yeast
SU1514777A1 (en) * 1987-06-30 1989-10-15 Inst Molekulyarnoj Biolog An S Method of producing biomass of saccharomyces cerevisial yeast
CN1185484A (en) * 1996-12-11 1998-06-24 阿尔瓦罗·V·皮卡卢加 Method for regulating cell conduction

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU902462A1 (en) * 1980-03-26 1982-08-15 Отдел Биологии Дагестанского Филиала Ан Ссср Method for cultivating yeast
SU1514777A1 (en) * 1987-06-30 1989-10-15 Inst Molekulyarnoj Biolog An S Method of producing biomass of saccharomyces cerevisial yeast
CN1185484A (en) * 1996-12-11 1998-06-24 阿尔瓦罗·V·皮卡卢加 Method for regulating cell conduction

Cited By (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1375652A3 (en) * 2002-06-28 2004-01-07 Ultra Biotech Limited Oral compositions for HIV-Infected Subjects
EP1375651A3 (en) * 2002-06-28 2004-01-07 Ultra Biotech Limited Oral compositions for white blood cell activation and proliferation
US6984507B2 (en) 2003-06-11 2006-01-10 Ultra Biotech Limited Biological compositions and methods for treatment of lung cancer
US6984508B2 (en) 2003-06-11 2006-01-10 Ultra Biotech Limited Biological compositions and methods for treatment of cervical cancer
US6987012B2 (en) 2003-06-11 2006-01-17 Ultra Biotech Limited Biological compositions and methods for treatment of colorectal cancer
US6989253B2 (en) 2003-06-11 2006-01-24 Ultra Biotech Limited Biological compositions and methods for treatment of testicular cancer
US7201906B2 (en) 2003-06-11 2007-04-10 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7204988B2 (en) 2003-06-11 2007-04-17 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7204987B2 (en) 2003-06-11 2007-04-17 Ultra Biotech Limited Biological compositions and methods for treatment of prostate cancer
US7204986B2 (en) 2003-06-11 2007-04-17 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7208158B2 (en) 2003-06-11 2007-04-24 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7214377B2 (en) 2003-06-11 2007-05-08 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7220416B2 (en) 2003-06-11 2007-05-22 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7223403B2 (en) 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7223401B2 (en) 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7223405B2 (en) 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepareompositions comprising yeast treated with electromagnetic energy
US7223400B2 (en) 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7223404B2 (en) 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7223402B2 (en) 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7226600B2 (en) 2003-06-11 2007-06-05 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
WO2011023769A1 (en) * 2009-08-26 2011-03-03 Mb Milmed Ab Composition for treatment of neurodegenerative diseases or disorders, method and use comprising electromagnetically irradiated yeast
CN102481368A (en) * 2009-08-26 2012-05-30 密美德有限公司 Composition for treatment of neurodegenerative diseases or disorders, method and use comprising electromagnetically irradiated yeast
JP2013503138A (en) * 2009-08-26 2013-01-31 エムビー ミルメド エービー Compositions, methods and uses for the treatment of neurodegenerative diseases or disorders comprising electromagnetic radiation yeast
US9320768B2 (en) 2009-08-26 2016-04-26 Milmed Ab Composition for treatment of neurodegenerative diseases or disorders, method and use comprising electromagnetically irradiated yeast

Similar Documents

Publication Publication Date Title
WO2002062984A1 (en) The yeast with immunoregulation activity to the k cell as well as the production method and the use thereof
Karamać et al. Use of different proteases to obtain flaxseed protein hydrolysates with antioxidant activity
Sampson The evolution of the enablement and written description requirements under 35 USC § 112 in the area of biotechnology
WO2002062981A1 (en) A yeast human immunoregulator and the method for preparing it
WO2002062983A1 (en) A yeast with t cell immunoregulatory activity as well as the preparing method and the uses thereof
WO2002062985A1 (en) A yeast with nk cell immunoregulatory activity as well as the preparing method and the uses thereof
Guan et al. In vitro efficacy of Myxococcus fulvus ANSM068 to biotransform aflatoxin B1
WO2002062982A1 (en) A yeast having b cell immune regulation activity and its preparation method and application thereof
WO2005003168A3 (en) Methods for the production and cytotoxicity evaluation of kir2dl nk-receptor antibodies
WO2003078431A8 (en) Aza-bicyclic n-biarylamides with affinity for the alpha-7 nicotinic acetylcholine receptor
EP4269561A3 (en) Improved modalities for the treatment of degenerative diseases of the retina
Pfeiffer et al. Sensory processing, participation, and recovery in adults with serious mental illnesses.
WO2007117438A3 (en) Methods for the production of functional protein from dna having a nonsense mutation and the treatment of disorders associated therewith
WO2005046570A3 (en) Human stem cell materials and methods
WO2004007675A3 (en) Neuronal and optic nerve gene expression patterns
Kawa et al. Locomotor activity, object exploration and space preference in children with autism and Down syndrome
Ee et al. Effects of bromelain and trypsin hydrolysis on the phytochemical content, antioxidant activity, and antibacterial activity of roasted butterfly pea seeds
Sagu et al. Comprehensive characterization and relative quantification of α-amylase/trypsin inhibitors from wheat cultivars by targeted HPLC-MS/MS
Zieliński et al. ACE inhibitory properties and phenolics profile of fermented flours and of baked and digested biscuits from buckwheat
Li et al. Investigation of chlorella pyrenoidosa protein as a source of novel angiotensin I-converting enzyme (ACE) and dipeptidyl peptidase-IV (DPP-IV) inhibitory peptides
Galli et al. Antioxidant properties of sourdoughs made with whole grain flours of Hull-less barley or conventional and pigmented wheat and by selected lactobacilli strains
Ulvestad Psychoneuroimmunology: the experiential dimension
Chen et al. Development and optimization of djulis sourdough bread fermented by lactic acid bacteria for antioxidant capacity
WO2005058945A3 (en) Gene variants coding for proteins from the metabolic pathway of fine chemicals
Luti et al. Bioactive Properties of Breads Made with Sourdough of Hull-Less Barley or Conventional and Pigmented Wheat Flours

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 69(1) EPC

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP